ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,802Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 2094

$882K Total Retail Price of All Prescriptions

Rank: 143 out of 2094

338 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 338 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 9,453 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 479 417 1 1
AMLODIPINE BESYLATE 463 399 2 2
METOPROLOL TARTRATE 327 305 3 10
LEVOTHYROXINE SODIUM 271 214 4 3
NEXIUM 248 232 5 16
ENALAPRIL MALEATE 234 202 6 25
METFORMIN HCL 223 175 7 8
NAMENDA 210 209 8 32
DONEPEZIL HCL 207 194 9 20
OMEPRAZOLE 189 128 10 4
ZOLPIDEM TARTRATE 187 129 11 14
FUROSEMIDE 171 137 12 6
POTASSIUM CHLORIDE 169 138 13 24
DIOVAN 162 162 14 13
WARFARIN SODIUM 161 161 15 11
ISOSORBIDE MONONITRATE ER 151 144 16 57
METOPROLOL SUCCINATE 146 131 17 9
OXYCODONE-ACETAMINOPHEN 145 87 S2 18 40
HYDROCHLOROTHIAZIDE 132 126 19 12
LISINOPRIL 128 96 20 7
RISPERIDONE 125 63 21 56
TRAMADOL HCL 123 71 22 33
CARVEDILOL 117 93 23 19
MIRTAZAPINE 114 90 24 43
LIDODERM 104 85 25 59
DEXILANT 102 78 26 124
FAMOTIDINE 102 74 26 34
CRESTOR 101 93 28 15
DIOVAN HCT 100 99 29 28
BYSTOLIC 93 82 30 83
CLOPIDOGREL 92 71 31 22
PANTOPRAZOLE SODIUM 87 68 32 37
AGGRENOX 86 81 33 260
ATORVASTATIN CALCIUM 84 76 34 5
TAMSULOSIN HCL 83 71 35 29
ONGLYZA 79 77 36 134
HYDRALAZINE HCL 79 64 36 89
ADVAIR DISKUS 75 46 38 36
KLOR-CON M20 75 39 38 106
SERTRALINE HCL 73 72 40 26
CHLORTHALIDONE 72 64 41 200
ESCITALOPRAM OXALATE 71 44 42 46
GABAPENTIN 70 48 43 23
LOVAZA 68 66 44 53
PLAVIX 68 61 44 38
PAROXETINE HCL 68 60 44 77
GLYBURIDE-METFORMIN HCL 68 50 R 44 94
DIGOXIN 67 67 48 51
ATENOLOL 67 67 48 21
MELOXICAM 67 52 48 49
MECLIZINE HCL 65 65 51 103
AZITHROMYCIN 63 47 52 27
LANTUS 63 21 52 66
PROAIR HFA 63 48 52 45
HUMULIN N 61 0 55 356
LEVOFLOXACIN 59 43 56 70
LYRICA 58 56 57 85
CLONIDINE HCL 57 47 58 62
HYDROMORPHONE HCL 57 0 S2 58 225
BENICAR 56 52 60 108
FENTANYL 56 32 S2 60 68
CELEBREX 56 54 60 74
OXYCONTIN 52 17 S2 63 98
SPIRONOLACTONE 51 31 64 93
LOSARTAN POTASSIUM 51 46 64 17
DILTIAZEM 24HR CD 50 50 66 110
ACTOS 50 50 66 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.